Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis

Journal of Infectious Diseases

Volumn 194, Issue 9, 2006, Pages 1331-1339

  Van Till, J W Olivier ^a   Levi, Marcel ^a   Bresser, Paul ^a   Schultz, Marcus J ^a   Gouma, Dirk J ^a   Boermeester, Marja A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; PLASMINOGEN ACTIVATOR; PROCOAGULANT; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; FIBRINOLYSIS; HUMAN; LUNG LAVAGE; MALE; PERITONITIS; PRIORITY JOURNAL;

AGED; BLOOD COAGULATION; BRONCHOALVEOLAR LAVAGE FLUID; FACTOR VIIA; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PERITONITIS; SEPSIS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 33750311695     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/508290     Document Type: Article

References (36)

1. Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001; 29:S99-106.
2. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-92.
3. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-9.
4. Wickel DJ, Cheadle WG, Mercer-Jones MA, Garrison RN. Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann Surg 1997; 225:744-53.
5. Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intra-abdominal infections: multivariate analysis on 604 patients. Arch Surg 1996; 131:641-5.
6. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury: predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818-24.
7. Welty-Wolf KE, Carraway MS, Ortel TL, Piantadosi CA. Coagulation and inflammation in acute lung injury. Thromb Haemost 2002; 88: 17-25.
8. Idell S, James KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84:695-705.
9. Sabharwal AK, Bajaj SP, Ameri A, et al. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med 1995; 151:758-67.
10. Gunther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:454-62.
11. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-24.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
13. Binnema DJ, van Iersel JJ, Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 1986; 43:569-77.
14. Friederich PW, Levi M, Bauer KA, et al. Ability of recombinant factor Vila to generate thrombin during inhibition of tissue factor in human subjects. Circulation 2001; 103:2555-9.
15. Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48:266-9.
16. Peters M, Breederveld C, Kahle LH, Ten Cate JW. Rapid microanalysis of coagulation parameters by automated chromogenic substrated methods-application in neonatal patients. Thromb Res 1982; 28:773-81.
17. Choi G, Schultz MJ, Van Till JWO, et al. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 2004; 24:786-9.
18. Rijneveld AW, Weijer S, Bresser P, et al. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med 2006; 34:1725-30.
19. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67:2540-6.
20. Todoroki H, Nakamura S, Higure A, et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery 2000; 127:209-16.
21. Levi M, Van der Poll T, Ten Cate H, et al. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees. Am J Respir Crit Care Med 1998; 158:92-8.
22. Wygrecka M, Markart P, Ruppert C, et al. Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thromb Haemost 2004; 92:529-40.
23. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31:5213-20.
24. Nakstad B, Boye NP, Lyberg T. Procoagulant activities in human alveolar macrophages. Eur J Respir Dis 1987; 71:459-71.
25. McGee MP, Wallin R, Wheeler FB, Rothberger H. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study. Blood 1989; 74:1583-90.
26. Van Veen SQ, Levi M, Van Vliet AK, Florquin S, Van Gulik TM, Boermeester MA. Peritoneal lavage with APC alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. Crit Care Med 2006 (in press).
27. Seeger W, Elssner A, Gunther A, Kramer HJ, Kalinowski HO. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am J Respir Cell Mol Biol 1993; 9:213-20.
28. Meade MO, Cook RJ, Guyatt GH, et al. Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:85-90.
29. Seeger W, Hubel J, Klapettek K, et al. Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to the development of acute respiratory distress. Thromb Res 1991; 61:53-64.
30. Welty-Wolf KE, Carraway MS, Miller DL, et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001; 164:1988-96.
31. Carraway MS, Welty-Wolf KE, Miller DL, et al. Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003; 167:1200-9.
32. Welty-Wolf KE, Carraway MS, Ortel TL, et al. Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol 2006; 290:L21-31.
33. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91:2850-60.
34. Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290:238-47.
35. Van Till JWO, Lamme B, Van Esch TJ, Van der Poll T, Van Gulik TM, Boermeester MA. Surgical therapy attenuates abdominal and extraabdominal inflammation in experimental peritonitis. Eur Surg Res 2006; 38:76-82.
36. Dugernier TL, Laterre PF, Wittebole X, et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003; 168:148-57.